Limited diversity of human scFv fragments isolated by panning a synthetic phage-display scFv library with cultured human melanoma cells

Journal of Immunology

Volumn 161, Issue 6, 1998, Pages 2968-2976

  Noronha, Elvyra J ^a   Wang, Xinhui ^a   Desai, Smruti A ^a   Kageshita, Toshiro ^a   Ferrone, Soldano ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; MELANOMA ANTIGEN; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MELANOMA CELL; MOLECULAR WEIGHT; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBODY DIVERSITY; BINDING SITES, ANTIBODY; CARBOHYDRATES; EPITOPE MAPPING; EPITOPES; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; INOVIRIDAE; MELANOMA; MICE; MICE, INBRED BALB C; MOLECULAR WEIGHT; NEOPLASM PROTEINS; NEUROGLIA; PEPTIDE LIBRARY; RATS; SEQUENCE ANALYSIS, DNA; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0032530949     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Reisfeld, R. A., and D. A. Cheresh. 1987. Human tumor antigens. Adv. Immunol. 40:323.
2. Herlyn, M., and H. Koprowski. 1988. Melanoma antigens: immunological and biological characterization and clinical significance. Annu. Rev. Immunol. 6:283.
3. Graf, L. H., Jr., and S. Ferrone. 1989. Human melanoma-associated antigens. In Human Immunogenetics: Basic Principles and Clinical Relevance. S.D. Litwin, ed. Marcel Dekker, Inc., New York and Basel, p. 643.
4. 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy. J. Clin. Invest. 72:2101.
5. Houghton, A. N., D. Mintzer, C. Cordon-Cardo, S. Welt, B. Fliegel, S. Vadhan, E. Carswell, M. R. Melamed, H. F. Oettgen, and L. J. Old. 1985. Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma. Proc. Natl. Acad. Sci. USA 82:1242.
6. Siccardi, A. G., G. L. Buraggi, L. Callegaro, G. Mariani, P. G. Natali, A. Abbati, M. Bestagno, V. Caputo, L. Mansi, R. Masi, et al. 1986. Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma. Cancer Res. 46:4817.
7. Mittelman, A., Z. J. Chen, T. Kageshita, H. Yang, M. Yamada, P. Baskind, N. Goldberg, C. Puccio, T. Ahmed, Z. Arlin, and S. Ferrone. 1990. Active specific immunotherapy in patients with melanoma: a clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high molecular weight melanoma-associated antigen monoclonal antibodies. J. Clin. Invest. 86: 2136.
8. Spitler, L. E., M. del Rio, A. Khentigan, N. I. Wedel, N. A. Brophy, L. L. Miller, W. S. Harkonen, L. L. Rosendorf, H. M. Lee, R. P. Mischak, R. T. Kawahata, J. B. Stoudemire, L. B. Fradkin, E. E. Bautista, and P. J. Scannon. 1987. Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin. Cancer Res. 47:1717.
9. Ferrone, S., and M. A. Pellegrino. 1979. Serological detection of human melanoma-associated antigens. In Cancer Immunodiagnosis. R. B. Herberman and R. McIntire, eds. Marcel Dekker, New York, p. 588.
10. Irie, R. F., L. L. Sze, and R. E. Saxton. 1982. Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines. Proc. Natl. Acad. Sci. USA 79:5666.
11. Houghton, A. N., H. Brooks, R. J. Cote, M. C. Taormina, H. F. Oettgen, and L. J. Old. 1983. Detection of cell surface and intracellular antigens by human monoclonal antibodies: hybrid cell lines derived from lymphocytes of patients with malignant melanoma. J. Exp. Med. 158:53.
12. Kan-Mitchell, J., A. Imam, R. A. Kempf, C. R. Taylor, and M. S. Mitchell. 1986. Human monoclonal antibodies directed against melanoma tumor-associated antigens. Cancer Res. 46:2490.
13. Sahin, U., O. Tureci, H. Schmitt, B. Cochlovius, T. Johannes, R. Schmits, F. Stenner, G. Luo, I. Schoben, and M. Pfreundschuh. 1995. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA 92:11810.
14. Tureci, O., U. Sahin, I. Schobert, M. Koslowski, H. Schmitt, H. J. Schild, F. Stenner, G. Seitz, H. G. Rammensee, and M. Pfreundschuh. 1996. The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res. 56:4766.
15. Cai, X., and A. Garen. 1995. Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells: selection of specific antibodies from single-chain Fv fusion phage libraries. Proc. Natl. Acad. Sci. USA 92:6537.
16. H antibody cloned from a fusion phage library of a vaccinated melanoma patient. Proc. Natl. Acad. Sci. USA 93:6280.
17. Pereira, S., P. Van Belle, D. Elder, H. Maruyama, L. Jacob, M. Sivanandham, M. Wallack, D. Siegel, and D. Herlyn. 1997. Combinatorial antibodies against human malignant melanoma. Hybridoma 16:11.
18. Desai, S. A., X. Wang, E. J. Noronha, T. Kageshita, and S. Ferrone. 1998. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv antibodies isolated from a phage display antibody library. Cancer Res. 58:2417.
19. Nissim, A., H. R. Hoogenboom, I. M. Tomlinson, G. Flynn, C. Midgley, D. Lane, and G. Winter. 1994. Antibody fragments from a "single pot" phage display library as immunochemical reagents. EMBO J. 13:692.
20. Wilson, B. S., K. Imai, P. G. Natali, and S. Ferrone. 1981. Distribution and molecular characterization of a cell surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies. Int. J. Cancer 28:293.
21. Giacomini, P., A. K. Ng, R. R. Kantor, P. G. Natali, and S. Ferrone. 1983. Double-determinant immunoassay to measure a human high-molecular-weight melanoma-associated antigen. Cancer Res. 43:3586.
22. Chen, Z. J., H. Yang, T. Kageshita, and S. Ferrone. 1991. Human high-molecular-weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody TK7-371. Cancer Res. 51:4790.
23. Temponi, M., R. A. Fawwaz, U. Kekish, T. S. Wang, and S. Ferrone. 1991. Improvement by affinity chromatography on antiidiotypic monoclonal antibodies (mAbs) of immunoreactivity and in vivo targeting of radiolabeled anti-HMW-MAA mAb TP61.5 in nude mice bearing human melanoma lesions. Int. J. Cancer 49:624.
24. Imai, K., B. S. Wilson, A. Bigotti, P. G. Natali, and S. Ferrone. 1982. A 94,000-Dalton glycoprotein expressed by human melanoma and carcinoma cells. J. Natl. Cancer Inst. 68:761.
25. 2m gene expression. J. Clin. Invest. 87:284.
26. Pellegrino, M. A., A.-K. Ng, C. Russo, and S. Ferrone. 1982. Heterogeneous distribution of the determinants defined by monoclonal antibodies on HLA-A and -B antigens bearing molecules. Transplantation 34:18.
27. Kusama, M., T. Kageshita, Z. J. Chen, and S. Ferrone. 1989. Characterization of syngeneic antiidiotypic monoclonal antibodies to murine anti-human high molecular weight melanoma-associated antigen monoclonal antibodies. J. Immunol. 143:3844.
28. Nishiyama, A., and W. B. Stallcup. 1993. Expression of NG2 proteoglycan causes retention of type VI collagen on the cell surface. Mol. Biol. Cell 4:1097.
29. Evan, G. I., G. K. Lewis, G. Ramsay, and J. M. Bishop. 1985. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell Biol. 5:3610.
30. Wang, X., S. Desai, E. J. Noronha, A. Mittelman, and S. Ferrone. 1997. The anti-idiotypic approach to active specific immunotherapy of malignant melanoma. In Idiotypes in Medicine: Autoimmunity, Infection, and Cancer. Y. Shoenfeld, R. C. Kennedy, and S. Ferrone, eds. Elsevier Publishers B.V., Amsterdam, p. 523.
31. Temponi, M., T. Kageshita, F. Perosa, R. Ono, H. Okada, and S. Ferrone. 1989. Purification of murine IgG monoclonal antibodies by precipitation with caprylic acid: comparison with other methods of purification. Hybridoma 8:85.
32. Marks, J. D., H. R. Hoogenboom, T. P. Bonnert, J. McCafferty, A. D. Griffiths, and G. Winter. 1991. Bypassing immunization: human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222:581.
33. H gene segments rearranged in vitro. J. Mol. Biol. 227:381.
34. Marks, J. D., W. H. Ouwehand, J. M. Bye, R. Finnern, B. D. Gorick, D. Voak, S. J. Thorpe, N. C. Hughes-Jones, and G. Winter. 1993. Human antibody fragments specific for human blood group antigens from a phage display library. Biotechnology 11:1145.
35. Miller, J. H. 1972. Experiments in Molecular Genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
36. Schier, R., J. Bye, G. Apell, A. McCall, G. P. Adams, M. Malmqvist, L. M. Weiner, and J. D. Marks. 1996. Isolation of high-affinity monomeric human anti-c-erbB-2 single-chain Fv using affinity-driven selection. J. Mol. Biol. 255:28.
37. Skerra, A., and A. Pluckthun. 1988. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 240:1038.
38. H segments with different hypervariable loops. J. Mol. Biol. 227:776.
39. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463.
40. Tomlinson, I. M., S. C Williams, S. J. Corbett, J. P. Cox, and G. Winter. 1995. V BASE sequence directory. Medical Research Council Centre for Protein Engineering, Cambridge, U.K.
41. Zweig, S. E., and E. M. Shevach. 1983. Production and properties of monoclonal antibodies to guinea pig Ia antigens. Methods Enzymol. 92:66.
42. Spiro, R. C., H. E. Casteel, D. M. Laufer, R. A. Reisfeld, and J. R. Harper. 1989. Post-translational addition of chondroitin sulfate glycosaminoglycans: role of N-linked oligosaccharide addition, trimming, and processing. J. Biol. Chem. 264: 1779.
43. Duksin, D., and P. Bornstein. 1977. Changes in surface properties of normal and transformed cells caused by tunicamycin, an inhibitor of protein glycosylation. Proc. Natl. Acad. Sci. USA 74:3433.
44. Liao, S. K., J. W. Smith, P. C. Kwong, P. G. Natali, M. Kusama, C. V. Hamby, and S. Ferrone. 1987. Cross-reactivity of murine anti-human high molecular weight melanoma-associated antigen monoclonal antibodies with guinea pig melanoma cells. Cancer Res. 47:4835.
45. Nishiyama, A., K. J. Dahlin, J. T. Prince, S. R. Johnstone, and W. B. Stallcup. 1991. The primary structure of NG2, a novel membrane-spanning proteoglycan. J. Cell Biol. 114:359.
46. Pluschke, G., M. Vanek, A. Evans, T. Dittmar, P. Schmid, P. Itin, E. J. Filardo, and R. A. Reisfeld. 1996. Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan. Proc. Natl. Acad. Sci. USA 93:9710.
47. Bumol, T. F., and R. A. Reisfeld. 1982. Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells. Proc. Natl. Acad. Sci. USA 79:1245.
48. Hellstrom, I., H. J. Garrigues, L. Cabasco, G. H. Mosely, J. P. Brown, and K. E. Hellstrom. 1983. Studies of a high molecular weight human melanoma-associated antigen. J. Immunol. 130:1467.
49. Kantor, R. R. S., A. P. Albino, A. K. Ng, and S. Ferrone. 1986. Biosynthesis and intracellular processing of four human melanoma-associated antigens. Cancer Res. 46:5223.
50. Thomson, T. M., M. J. Mattes, L. Roux, L. J. Old, and K. O. Lloyd. 1985. Pigmentation-associated glycoprotein of human melanomas and melanocytes: definition with a mouse monoclonal antibody. J. Invest. Dermatol. 85:169.
51. Furukawa, K. S., K. Furukawa, F. X. Real, L. J. Old, and K. O. Lloyd. 1989. A unique antigenic epitope of human melanoma is carried on the common melanoma glycoprotein gp95/p97. J. Exp. Med. 169:585.